Make Every Step Count: Personalised Music Feedback to Walking for People Living With COPD
MuSiC
Personalised Music Feedback to Optimise Adherence to the Walking Exercise Prescription During Pulmonary Rehabilitation for Individuals Living With Chronic Obstructive Pulmonary Disease
1 other identifier
interventional
30
1 country
2
Brief Summary
Pulmonary Rehabilitation (PR) is an evidence-based intervention to effectively manage the physiological and psychological effects of Chronic Obstructive Pulmonary Disease (COPD). The aims of PR are to improve symptoms of COPD, increase exercise capacity, increase independency, improve overall behaviour related to health (like exercising more), and enhance quality of life. The cornerstone of PR programmes is aerobic exercise prescription. Typically, walking exercise is used, and the prescription is individualised for each patient based on their maximal walking exercise capacity. However, adherence to walking exercise is challenging for service users, particularly when unsupervised at home. The use of music during exercise shows promise as a tool to decrease the perception of fatigue and increase motivation, but the integration of music via smartphone applications to support walking exercise adherence during PR has not been explored. This project aims to assess if a new mobile application BeatClearWalker (BCW) intervention is practical, acceptable, and effectively used by people living with COPD. The app is designed to help people living with COPD attending PR adhere to their prescribed walking pace during exercise. The BCW app provides real-time, personalised music feedback through music degradation to optimise the dose of walking exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2025
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2024
CompletedFirst Posted
Study publicly available on registry
October 8, 2024
CompletedStudy Start
First participant enrolled
April 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 26, 2025
CompletedApril 16, 2025
April 1, 2025
5 months
September 26, 2024
April 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
The proportion of recruited participants who do not use the BCW app.
Post PR 6-8 weeks.
The proportion of recruited participants who complete the follow-up assessment.
Upon the completion of the PR programme at 6-8 weeks.
The proportion of patients who meet the eligibility criteria.
The percentage of eligible from those who were screened against the eligibility criteria
11 months
The proportion of individuals with COPD who express interest in participating in the study.
11 months
The proportion of eligible participants who provide consent to enrol.
After meeting the eligibility criteria at the screening stage.
11 months
Secondary Outcomes (15)
Medical Research Council (MRC) Dyspnoea Scale
Baseline (Pre-PR) and Follow-up (Post-PR, at 6-8 weeks).
Generic Health Status Questionnaire (EQ-5D-5L)
Baseline (Pre-PR) and Follow-up (Post-PR, at 6-8 weeks).
Generalized Anxiety Disorder 2-item (GAD-2)
Baseline (Pre-PR) and Follow-up (Post-PR, at 6-8 weeks).
Generalized Anxiety Disorder 7-item (GAD-7)
Baseline (Pre-PR) and Follow-up (Post-PR, at 6-8 weeks).
Walking exercise time at an individually prescribed cadence over the total time spent in walking exercise (Percent).
Data collected after each walking exercise session during the PR programme (6-8 weeks).
- +10 more secondary outcomes
Study Arms (1)
Music Walking Application BeatClearWalker (BCW)
EXPERIMENTALAs it is a single-arm feasibility study, all participants will be allocated to one arm, receiving routine personalised walking exercise while listening to music from the smartphone using the music walking application BeatClearWalker during their Pulmonary rehabilitation Programme.
Interventions
The music walking application (BCW) is a smartphone application that can monitor the walking pace and allow individuals to listen to music and give immediate feedback so they can correct their walking pace to match their target walking speed, as prescribed by the healthcare professional. The application provides real-time audio feedback in the form of music; the music sound quality will reduce whenever the walking speed drops below or exceeds the participant\'s target walking speed. Simply, the application will work to supervise service users while exercising walking. The investigators are trying to assess the feasibility of this application with service users during their Pulmonary Rehabilitation programme (at the hospital/ home) to find out how participants interact with listening to music while exercise walking and how well they're able to keep to their target speed.
Eligibility Criteria
You may qualify if:
- Willing and able to provide informed consent for participation in the study.
- The patient is referred for PR at the UHL.
- The patient has a confirmed diagnosis of COPD using spirometry (based on GOLD criteria)
- Male or female, aged 18+ years.
- Able to communicate in written and spoken English.
You may not qualify if:
- Unable to provide valid informed consent.
- Lack of motivation to participate in PR programme.
- Any-contra-indications absolute or relative to exercise training.
- Has had a cardiac event within last 6 weeks
- Severe psychiatric disorders
- Patients with a history of MRSA +ve screens (patients can be assessed and given an exercise programme but cannot attend the classes. Patients need to have 3 consecutive -ve MRSA swabs before they can attend).
- Unable to understand written or spoken English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Leicesterlead
- University of Strathclydecollaborator
- University Hospitals, Leicestercollaborator
Study Sites (2)
NIHR Leicester Biomedical Research Centre - Respiratory
Leicester, Leicestershire, LE3 9QP, United Kingdom
University Hospitals of Leicester (UHL)
Leicester, Leicestershire, LE3 9QP, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark Orme, PhD
University of Leicester
- STUDY DIRECTOR
Linzy Houchen-Wolloff, PhD
NIHR Leicester Biomedical Research Centre - Respiratory, University Hospitals of Leicester NHS Trust
- STUDY CHAIR
Sally J Singh, PhD
NIHR Leicester Biomedical Research Centre - Respiratory, University Hospitals of Leicester NHS Trust
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 26, 2024
First Posted
October 8, 2024
Study Start
April 20, 2025
Primary Completion
September 12, 2025
Study Completion
September 26, 2025
Last Updated
April 16, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share